• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Health

    Can personalized medicine alter South Africa's fight against HIV?

    South Africa's HIV Host Genome Project seeks to unlock the genetic factors that enable a rare group of HIV-positive individuals, known as "elite controllers," to naturally suppress the virus without needing antiretroviral medication.

    By Paul Adepoju // 31 October 2024

    In South Africa, a country long struggling with one of the world's highest rates of HIV infection, a quiet yet ambitious health care transformation is taking shape. South Africa is pushing to integrate personalized medicine — using genetic data to tailor treatments — into its public health framework. This move could reshape health care for millions, potentially transforming the country into a leader in genomics-driven medicine on the African continent.

    However, the colossal undertaking demands significant changes in infrastructure, regulatory frameworks, and public health policies. For its advocates, however, these are necessary steps toward a future where treatments are customized to the genetic makeup of individuals rather than taking a one-size-fits-all approach.

    "We’re not just aiming for innovation here," Veron Ramsuran, an associate professor at the University of KwaZulu-Natal, told Devex. "We want personalized medicine to become a cornerstone of public health in South Africa."

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    More reading:

    ► Spoiled for choice? What's blocking uptake of HIV prevention tools

    ► Activists demand access to groundbreaking HIV prevention tool

    ► Does HIV need a rebrand?

    • Global Health
    • Research
    • Social/Inclusive Development
    • Trade & Policy
    • South Africa
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Paul Adepoju

      Paul Adepojupauladepoju

      Paul Adepoju is a Nigeria-based Devex Contributing Reporter, academic, and author. He covers health and tech in Africa for leading local and international media outlets including CNN, Quartz, and The Guardian. He's also the founder of healthnews.africa. He is completing a doctorate in cell biology and genetics and holds several reporting awards in health and tech.

    Search for articles

    Related Stories

    Global HealthWill infants finally have access to a highly effective HIV drug?

    Will infants finally have access to a highly effective HIV drug?

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global HealthThe urgent need to rethink Africa's health financing

    The urgent need to rethink Africa's health financing

    Global healthAmid global health funding cuts, Africa is struggling with opioid abuse

    Amid global health funding cuts, Africa is struggling with opioid abuse

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      FCDO's top development contractors in 2024/25
    • 3
      How AI-powered citizen science can be a catalyst for the SDGs
    • 4
      Strengthening health systems by measuring what really matters
    • 5
      Opinion: India’s bold leadership in turning the tide for TB
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement